78 related articles for article (PubMed ID: 23517560)
1. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
[TBL] [Abstract][Full Text] [Related]
2. The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract.
Zaher M; Mirshahi M; Nuraliev Y; Sharofova M; Bombarda I; Marie JP; Billard C
Int J Oncol; 2011 Oct; 39(4):965-72. PubMed ID: 21750864
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
[TBL] [Abstract][Full Text] [Related]
4. Genetically defining the mechanism of Puma- and Bim-induced apoptosis.
Garrison SP; Phillips DC; Jeffers JR; Chipuk JE; Parsons MJ; Rehg JE; Opferman JT; Green DR; Zambetti GP
Cell Death Differ; 2012 Apr; 19(4):642-9. PubMed ID: 22015606
[TBL] [Abstract][Full Text] [Related]
5. Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation.
Barthson J; Germano CM; Moore F; Maida A; Drucker DJ; Marchetti P; Gysemans C; Mathieu C; Nuñez G; Jurisicova A; Eizirik DL; Gurzov EN
J Biol Chem; 2011 Nov; 286(45):39632-43. PubMed ID: 21937453
[TBL] [Abstract][Full Text] [Related]
6. P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition.
Valverde-Lopez JA; Li-Bao L; Sierra R; Santos E; Giovinazzo G; Díaz-Díaz C; Torres M
PLoS Genet; 2024 Mar; 20(3):e1011193. PubMed ID: 38489392
[TBL] [Abstract][Full Text] [Related]
7. Optimizing frontline therapy of CLL based on clinical and biological factors.
Fischer K; Hallek M
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):338-345. PubMed ID: 29222276
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.
Schuler F; Afreen S; Manzl C; Häcker G; Erlacher M; Villunger A
EMBO Rep; 2019 Aug; 20(8):e47026. PubMed ID: 31379128
[TBL] [Abstract][Full Text] [Related]
9. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Kujawski L; Ouillette P; Erba H; Saddler C; Jakubowiak A; Kaminski M; Shedden K; Malek SN
Blood; 2008 Sep; 112(5):1993-2003. PubMed ID: 18436738
[TBL] [Abstract][Full Text] [Related]
10. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
11. The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia.
Wang C; Wang X
Int J Clin Exp Pathol; 2013; 6(7):1223-9. PubMed ID: 23826404
[TBL] [Abstract][Full Text] [Related]
12. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.
Zent CS; Kay NE
Leuk Lymphoma; 2011 Aug; 52(8):1425-34. PubMed ID: 21649549
[TBL] [Abstract][Full Text] [Related]
14. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.
Frezzato F; Gattazzo C; Martini V; Trimarco V; Teramo A; Carraro S; Cabrelle A; Ave E; Facco M; Zambello R; Tibaldi E; Brunati AM; Semenzato G; Trentin L
PLoS One; 2012; 7(6):e39902. PubMed ID: 22768161
[TBL] [Abstract][Full Text] [Related]
15. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.
Secchiero P; Barbarotto E; Gonelli A; Tiribelli M; Zerbinati C; Celeghini C; Agostinelli C; Pileri SA; Zauli G
Am J Pathol; 2005 Dec; 167(6):1599-607. PubMed ID: 16314473
[TBL] [Abstract][Full Text] [Related]
16. Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions.
Molica S; Tam C; Allsup D; Polliack A
Hematol Oncol; 2024 Jan; 42(1):e3238. PubMed ID: 37937506
[TBL] [Abstract][Full Text] [Related]
17. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers.
Diepstraten ST; Yuan Y; La Marca JE; Young S; Chang C; Whelan L; Ross AM; Fischer KC; Pomilio G; Morris R; Georgiou A; Litalien V; Brown FC; Roberts AW; Strasser A; Wei AH; Kelly GL
Cancer Cell; 2024 May; 42(5):850-868.e9. PubMed ID: 38670091
[TBL] [Abstract][Full Text] [Related]
18. PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis.
Carter MJ; Cox KL; Blakemore SJ; Turaj AH; Oldham RJ; Dahal LN; Tannheimer S; Forconi F; Packham G; Cragg MS
Leukemia; 2017 Jun; 31(6):1423-1433. PubMed ID: 27843137
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance.
Bistué-Rovira À; Rico LG; Bardina J; Juncà J; Granada I; Bradford JA; Ward MD; Salvia R; Solé F; Petriz J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396682
[TBL] [Abstract][Full Text] [Related]
20. Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome.
Rigo A; Vaisitti T; Laudanna C; Terrabuio E; Micillo M; Frusteri C; D'Ulivo B; Merigo F; Sbarbati A; Mellert K; Möeller P; Montresor A; Di Napoli A; Cirombella R; Butturini E; Massaia M; Constantin G; Vinante F; Deaglio S; Ferrarini I
Cell Death Dis; 2024 May; 15(5):323. PubMed ID: 38724507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
